233 related articles for article (PubMed ID: 11530188)
1. Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice.
Smee DF; Bailey KW; Wong MH; Sidwell RW
Antiviral Res; 2001 Oct; 52(1):55-62. PubMed ID: 11530188
[TBL] [Abstract][Full Text] [Related]
2. Effects of four antiviral substances on lethal vaccinia virus (IHD strain) respiratory infections in mice.
Smee DF; Wong MH; Bailey KW; Beadle JR; Hostetler KY; Sidwell RW
Int J Antimicrob Agents; 2004 May; 23(5):430-7. PubMed ID: 15120719
[TBL] [Abstract][Full Text] [Related]
3. Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir.
Smee DF; Bailey KW; Sidwell RW
Antivir Chem Chemother; 2001 Jan; 12(1):71-6. PubMed ID: 11437324
[TBL] [Abstract][Full Text] [Related]
4. Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir.
Smee DF; Bailey KW; Wong M; Sidwell RW
Antiviral Res; 2000 Sep; 47(3):171-7. PubMed ID: 10974369
[TBL] [Abstract][Full Text] [Related]
5. Treatment of cowpox virus respiratory infections in mice with ribavirin as a single agent or followed sequentially by cidofovir.
Smee DF; Bailey KW; Sidwell RW
Antivir Chem Chemother; 2000 Jul; 11(4):303-9. PubMed ID: 10950392
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of N-methanocarbathymidine in treating mice infected intranasally with the IHD and WR strains of vaccinia virus.
Smee DF; Hurst BL; Wong MH; Glazer RI; Rahman A; Sidwell RW
Antiviral Res; 2007 Nov; 76(2):124-9. PubMed ID: 17658623
[TBL] [Abstract][Full Text] [Related]
7. Therapy and long-term prophylaxis of vaccinia virus respiratory infections in mice with an adenovirus-vectored interferon alpha (mDEF201).
Smee DF; Wong MH; Russell A; Ennis J; Turner JD
PLoS One; 2011; 6(10):e26330. PubMed ID: 22022603
[TBL] [Abstract][Full Text] [Related]
8. Topical cidofovir is more effective than is parenteral therapy for treatment of progressive vaccinia in immunocompromised mice.
Smee DF; Bailey KW; Wong MH; Wandersee MK; Sidwell RW
J Infect Dis; 2004 Sep; 190(6):1132-9. PubMed ID: 15319864
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of cidofovir and cyclic HPMPC on lethal cowpox and vaccinia virus respiratory infections in mice.
Smee DF; Bailey KW; Sidwell RW
Chemotherapy; 2003 Jun; 49(3):126-31. PubMed ID: 12815205
[TBL] [Abstract][Full Text] [Related]
10. Treatment of lethal cowpox virus respiratory infections in mice with 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine and its orally active diacetate ester prodrug.
Smee DF; Bailey KW; Sidwell RW
Antiviral Res; 2002 May; 54(2):113-20. PubMed ID: 12062396
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) mice.
Neyts J; De Clercq E
J Med Virol; 1993 Nov; 41(3):242-6. PubMed ID: 8263505
[TBL] [Abstract][Full Text] [Related]
12. Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses.
Smee DF; Sidwell RW; Kefauver D; Bray M; Huggins JW
Antimicrob Agents Chemother; 2002 May; 46(5):1329-35. PubMed ID: 11959564
[TBL] [Abstract][Full Text] [Related]
13. Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir.
Quenelle DC; Collins DJ; Wan WB; Beadle JR; Hostetler KY; Kern ER
Antimicrob Agents Chemother; 2004 Feb; 48(2):404-12. PubMed ID: 14742188
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of multiple- or single-dose cidofovir against vaccinia and cowpox virus infections in mice.
Quenelle DC; Collins DJ; Kern ER
Antimicrob Agents Chemother; 2003 Oct; 47(10):3275-80. PubMed ID: 14506041
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the E9L polymerase gene of cidofovir-resistant vaccinia virus strain WR are associated with the drug resistance phenotype.
Kornbluth RS; Smee DF; Sidwell RW; Snarsky V; Evans DH; Hostetler KY
Antimicrob Agents Chemother; 2006 Dec; 50(12):4038-43. PubMed ID: 16982794
[TBL] [Abstract][Full Text] [Related]
16. Lack of efficacy of aurintricarboxylic acid and ethacrynic acid against vaccinia virus respiratory infections in mice.
Smee DF; Hurst BL; Wong MH
Antivir Chem Chemother; 2010 Apr; 20(5):201-5. PubMed ID: 20413827
[TBL] [Abstract][Full Text] [Related]
17. Effects of cidofovir treatment on cytokine induction in murine models of cowpox and vaccinia virus infection.
Knorr CW; Allen SD; Torres AR; Smee DF
Antiviral Res; 2006 Nov; 72(2):125-33. PubMed ID: 16782209
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of cidofovir in a murine model of disseminated progressive vaccinia.
Neyts J; Leyssen P; Verbeken E; De Clercq E
Antimicrob Agents Chemother; 2004 Jun; 48(6):2267-73. PubMed ID: 15155231
[TBL] [Abstract][Full Text] [Related]
19. Characterization and treatment of cidofovir-resistant vaccinia (WR strain) virus infections in cell culture and in mice.
Smee DF; Wandersee MK; Bailey KW; Hostetler KY; Holy A; Sidwell RW
Antivir Chem Chemother; 2005; 16(3):203-11. PubMed ID: 16004083
[TBL] [Abstract][Full Text] [Related]
20. Aerosolized cidofovir is retained in the respiratory tract and protects mice against intranasal cowpox virus challenge.
Roy CJ; Baker R; Washburn K; Bray M
Antimicrob Agents Chemother; 2003 Sep; 47(9):2933-7. PubMed ID: 12936997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]